Onderzoeker
Karel Fostier
- Trefwoorden:Geneeskunde
Affiliaties
- Hematologie (Onderzoeksgroep)
Lid
Vanaf22 mrt 2021 → Heden - Hematologie (Departement)
Lid
Vanaf1 jan 2013 → Heden - Hematologie (Departement)
Lid
Vanaf1 feb 2019 → 13 feb 2022 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf22 jun 2017 → 7 sep 2017 - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 dec 2015 → 30 nov 2017 - Basis (bio)-medische wetenschappen (Departement)
Lid
Vanaf1 dec 2015 → 2 dec 2015 - Interne Geneeskunde (Departement)
Lid
Vanaf1 sep 2010 → 31 dec 2012 - Interne Geneeskunde (Departement)
Lid
Vanaf1 jul 2009 → 31 aug 2009 - Fysiologie (Departement)
Lid
Vanaf1 okt 2006 → 30 jun 2009 - Fysiologie (Departement)
Lid
Vanaf1 okt 2006 → 30 jun 2009 - Laboratorium voor Moleculaire en Cellulaire Therapie (Onderzoeksgroep)
Lid
Vanaf1 sep 2006 → 19 mrt 2021
Publicaties
1 - 10 van 24
- Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Auteurs: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Rik Schots, Ivan Van Riet, M.H.C. Bakkus
Pagina's: 599-611 - COVID-19, impact on myeloma patients(2020)
Auteurs: Inès Dufour, Juliette Raedemaeker, Fabio Andreozzi, Géraldine Verstraete, Sarah Bailly, Michel Delforge, Pauline Storms, Caroline Jacquy, Ann Van de Velde, Philippe Mineur, et al.
Pagina's: 1947-1949 - Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients(2019)
Auteurs: Eileen M Boyle, Xavier Leleu, Marie-Odile Petillon, Lionel Karlin, Chantal Doyen, Hélène Demarquette, Bruno Royer, Margaret Macro, Philippe Moreau, Karel Fostier, et al.
Pagina's: 319-327 - Antigen excess detection by automated assays for free light chains(2018)
Auteurs: Xavier Bossuyt, Michel Delforge, Martin Reynders, Doreen Dillaerts, Ben Sprangers, Karel Fostier, Koen Poesen, Martine Vercammen
Pagina's: E235-E238 - Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition(2018)
Auteurs: G Awada, Teofila Seremet, Karel Fostier, Hendrik Everaert, Bart Neyns
Pagina's: 2156-2158 - Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used(2018)
Auteurs: Xavier Bossuyt, Michel Delforge, Martin Reynders, Doreen Dillaerts, Ben Sprangers, Karel Fostier, Koen Poesen, Martine Vercammen
Pagina's: 1815-1818 - Child-onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13(2018)
Auteurs: An-Sofie Schelpe, Christelle Orlando, Bogaç Ercig, Chloë Geeroms, Inge Pareyn, Nele Vandeputte, Leydi Carolina Velásquez Pereira, Elien Roose, Karel Fostier, Gerry A F Nicolaes, et al.
Pagina's: 191-199 - Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation(2018)
Auteurs: Karel Fostier, Jo Caers, Nathalie Meuleman, Jurgen Corthals, Brenda De Keersmaecker
Pagina's: 20476-20489 - Extracellular S100A9 protein in bone marrow supports multiple myeloma survival by stimulating angiogenesis and cytokine secretion(2017)
Auteurs: Kim De Veirman, Nathan De Beule, Ken Maes, Eline Menu, Elke De Bruyne, Hendrik De Raeve, Karel Fostier, Jerome Moreaux, Alboukadel Kassambara, Dirk Hose, et al.
Pagina's: 839-846 - Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report(2016)
Auteurs: Marieke Demeulenaere, Stephanie Du Four, Karel Fostier
Pagina's: 4145-4149